Skip to content

Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients

Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03881046
Enrollment
44
Registered
2019-03-19
Start date
2019-02-01
Completion date
2020-06-17
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The aim of our study was to compare the daily living activities with a performance-based protocol in lung cancer patients and healthy controls.

Detailed description

Lung cancer is the abnormal proliferation of cells in the lung tissue and a mass in the lung. The primary symptoms of this health problem include cough, dyspnea, chest pain, hemoptysis and sputum. In addition to these symptoms, muscle strength, respiratory function and effort level are decreased. Inadequate daily living activities in cancer patients are expressed.But studies evaluating the activities of daily living in patients with lung cancer are inadequate and patients are evaluated only using scales. For the measurement of functional status in daily living activities, these scales provide important information about the detection of symptoms and the progression of the disease. However, it is very difficult to determine the limitation of perceived difficulty in daily living activities with these scales. In addition, since these scales are a method of measurement, the objectivity is open to discussion. It is thought that a performance-based protocol will facilitate the detection of limitations and provide more objective findings. We think that the Londrina protocol fully reflects the activities of daily living and thus will give us an objective measurement. This study will show us the problem and its cause in daily life activities in patients with lung cancer.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* To have a diagnosis of lung cancer * Complete chemotherapy * Complete radiotherapy * Coopere, * Accepts participation in the study will be included in the study

Exclusion criteria

* Neurological, cognitive or orthopedic diseases that affect the measurements * Acute infection * Individuals with other chronic diseases that may affect their walking will not be included in the study

Design outcomes

Primary

MeasureTime frameDescription
Activities Of Daily Living1st dayDaily Living Activities will be evaluated using the Londrina Protocol.The protocol consists of 5 stations. Stations are including organizing books on the table, 18 meters walking by carrying 10% of body weight symmetrically, arranging books by putting them on shelves, hanging the laundry in the laundry basket and walking 18 meters. İndividual will do these activities at his own pace and the time will be recorded at the end.

Secondary

MeasureTime frameDescription
Life Quality1st DayQuality of life will be measured using Core Quality of Life Questionnaire (EORTC QLQ-C30) The questionnaire consists of 30 questions and provides information on quality of life and symptoms.
Peripheral Muscle Strength1st DayMuscle strength will be evaluated by force measuring dynamometer device 3 times. M.Quadriceps Femoris, shoulder abduction, shoulder flexion, elbow flexion, elbow extension and hand grip strength of all cases will be measured.
Dyspnoea1st DayDyspnoea will be evaluated using the Medical Research Council Dyspnoea Scale. The Medical Research Council Dyspnoea Scale has a score of 0-4. İn this scoring system 0 indicates that there is no dyspnoea, whereas 4 indicates that the dyspnoea is too high.
Respiratory Functions1st DayRespiratory functions will be measured by spirometric measurement. This measurement will give us FEV1 FVC FEV1 / FVC values.
Exercise Capacity1st Day6 Minute walk test will be used.In the test, the person will be asked to walk as fast as possible in a 30-meter corridor and the walking distance will be recorded in 6 minutes.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026